Aura Biosciences, Inc.
Support and Resistance Levels
Past performance
News About AURA
All events for AURA
All deals for AURA
Financial Ratios
Financial Statements
AURA vs Sector & Peers
About Aura Biosciences, Inc.
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases. Website aurabiosciences.com
Headquarters Boston, MA, US